<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id><journal-id journal-id-type="publisher-id">nar</journal-id><journal-title>Nucleic Acids Research</journal-title><issn pub-type="ppub">0305-1048</issn><issn pub-type="epub">1362-4962</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1093/nar/gkm473</article-id><article-id pub-id-type="pmid">17626052</article-id><article-categories><subj-group subj-group-type="heading"><subject>RNA</subject></subj-group></article-categories><title-group><article-title>Site-specific modification of <italic>Shigella flexneri virF</italic> mRNA by tRNA-guanine transglycosylase <italic>in vitro</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hurt</surname><given-names>Julie K.</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Olgen</surname><given-names>Sureyya</given-names></name><xref ref-type="aff" rid="AFF1"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Garcia</surname><given-names>George A.</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref><xref ref-type="corresp" rid="COR1">*</xref></contrib></contrib-group><aff id="AFF1"><sup>1</sup>Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109-1065 and <sup>2</sup>Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ankara University, TR-06100, Ankara, Turkey</aff><author-notes><corresp id="COR1">*To whom correspondence should be addressed.<phone>734 764 2202</phone><fax>734 647 8430</fax><email>gagarcia@umich.edu</email></corresp></author-notes><!--For NAR: both ppub and collection dates generated for PMC processing 1/27/05 beck--><pub-date pub-type="collection"><month>7</month><year>2007</year></pub-date><pub-date pub-type="ppub"><month>7</month><year>2007</year></pub-date><pub-date pub-type="epub"><day>10</day><month>7</month><year>2007</year></pub-date><volume>35</volume><issue>14</issue><fpage>4905</fpage><lpage>4913</lpage><history><date date-type="received"><day>17</day><month>4</month><year>2007</year></date><date date-type="rev-recd"><day>15</day><month>5</month><year>2007</year></date><date date-type="accepted"><day>29</day><month>5</month><year>2007</year></date></history><copyright-statement>&#x000a9; 2007 The Author(s)</copyright-statement><copyright-year>2007</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/uk/"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license><abstract><p><italic>Shigella flexneri</italic> is an enteropathogen responsible for severe dysentery in humans. VirF is a key transcriptional regulator that activates the expression of the downstream virulence factors required for cellular invasion and cell-to-cell spread of this pathogen. There are several environmental factors that induce the translation of VirF including temperature, pH, osmolarity and post-transcriptional RNA modification. Durand and colleagues (<italic>vacC</italic>, a virulence-associated chromosomal locus of <italic>Shigella flexneri</italic>, is homologous to <italic>tgt</italic>, a gene encoding tRNA-guanine transglycosylase of <italic>Escherichia coli</italic> K-12. <italic>J. Bacteriol</italic>., 176, 4627&#x02013;4634) have demonstrated a correlation between VirF and tRNA-guanine transglycosylase (TGT), which catalyzes the exchange of the hypermodified base queuine for the guanine in the wobble position of certain tRNAs. They characterized <italic>tgt</italic>- mutant <italic>S. flexneri</italic> strains in which the translation of VirF is markedly reduced and the bacteria are unable to invade host cells. Although the function of TGT is to modify tRNA, we report that the <italic>virF</italic> mRNA is recognized by the <italic>Escherichia coli</italic> TGT (99% identity to the <italic>S. flexneri</italic> TGT) <italic>in vitro</italic>. Further, we show that this recognition results in the site-specific modification of a single base in the <italic>virF</italic> mRNA. In the context of previous reports that small molecule binding motifs (&#x02018;riboswitches&#x02019;) in mRNAs modulate mRNA conformation and translation, our observations suggest that TGT may modulate the translation of VirF by base modification of the VirF encoding mRNA.</p></abstract></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>The occurrence of non-canonical nucleosides in RNA has been well-characterized (<xref ref-type="bibr" rid="B1 B2 B3 B4">1&#x02013;4</xref>), with &#x0223c;100 modified bases having been found in transfer RNA (tRNA) alone (<xref ref-type="bibr" rid="B5">5</xref>). Modifications occur at the post-transcriptional level, where some modifications are more simple chemical transformations (e.g. methylation) and still others are more complex (e.g. transglycosylation). One enzyme that performs a complex RNA modification (hypermodification) is tRNA-guanine transglycosylase (TGT, EC 2.4.2.29), catalyzing the exchange of the modified base queuine for the anticodon loop wobble position guanine in eukaryl and eubacterial tRNA<sup>Asp, Asn, His, Tyr</sup> (<xref ref-type="bibr" rid="B6">6</xref>). The proposed biochemical pathway for queuine incorporation in eubacterial tRNA is shown in <xref ref-type="fig" rid="F1">Figure 1</xref>. <fig id="F1" position="float"><label>Figure 1.</label><caption><p>Proposed biochemical pathway for queuine incorporation in eubacterial and eukaryl tRNA.</p></caption><graphic xlink:href="gkm473f1"/></fig></p><p>Although not yet fully understood, it is known that four genes are involved in the eubacterial biosynthesis of the queuine precursor, preQ<sub>1</sub> (<xref ref-type="bibr" rid="B7">7</xref>). PreQ<sub>1</sub> is incorporated into the tRNA by TGT (<xref ref-type="bibr" rid="B8">8</xref>). Two subsequent enzymes convert preQ<sub>1</sub> to queuine in the tRNA (<xref ref-type="bibr" rid="B8">8</xref>). In contrast, eukaryl organisms acquire queuine from external routes such as diet, and this heterocyclic base is incorporated directly by the eukaryl TGT (<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>).</p><p>TGT plays a vital role in the pathogenesis of shigellosis (<xref ref-type="bibr" rid="B11">11</xref>), a disease that causes severe dysentery in humans. The pathogenic strain, <italic>Shigella flexneri</italic>, infects the cells of the human gastrointestinal tract following evasion of the host immune system defense mechanisms, such as the engulfment of foreign substances by macrophages. <italic>Shigella</italic> is able to escape from the macrophage endosome via the expression of certain virulence factors (<xref ref-type="fig" rid="F2">Figure 2</xref>). There are several bacterial genes (including <italic>IcsA, IpaB, IpaC</italic> and <italic>IpaD</italic>) that mediate this escape as well as cell-to-cell spread of the organism (<xref ref-type="bibr" rid="B12">12</xref>). VirF, encoded on the primary pathogenicity island of <italic>Shigella</italic>, is a potent transcriptional regulator of the AraC family that regulates the expression of these virulence factors (<xref ref-type="fig" rid="F2">Figure 2</xref>) (<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>). <fig id="F2" position="float"><label>Figure 2.</label><caption><p>Schematic representation of <italic>Shigella</italic> pathogenesis. The invasion of the intestinal mucosal cells by <italic>S. flexneri</italic> is regulated by a number of virulence factors, including the transcriptional regulator, VirF. The VirF protein then activates the transcription of downstream virulence factors under the proper environmental conditions for invasion. Durand and colleagues (<xref ref-type="bibr" rid="B35">35</xref>) have shown that TGT is linked to the efficient translation of the VirF protein. Figure adapted from one provided by Prof. Ruth Brenk, University of Dundee.</p></caption><graphic xlink:href="gkm473f2"/></fig></p><p>There are several environmental factors that promote the expression of VirF, including oxygen and iron limitation, temperature, pH, osmolarity and post-transcriptional RNA modification (<xref ref-type="bibr" rid="B15">15</xref>). Durand and Bj&#x000f6;rk (<xref ref-type="bibr" rid="B11">11</xref>) have demonstrated a positive correlation between VirF and TGT by characterizing a mutant <italic>Shigella flexneri</italic> strain with an inactivated <italic>tgt</italic> gene (termed <italic>vacC</italic>). In this mutant, the translation of VirF was markedly reduced whereas the levels of <italic>virF</italic> mRNA remained unchanged, and as a result, the bacteria were unable to invade host cells. In addition, when transformed with a plasmid containing a functional <italic>Shigella tgt</italic> gene, restoring queuine modification, the <italic>Shigella</italic> mutants exhibited both restored VirF expression and virulence, thus demonstrating a positive connection between <italic>virF</italic> mRNA translation and the presence of active TGT (and presumably queuine modification).</p><p>The role of modified nucleosides in RNA structure and stability has been well-studied (<xref ref-type="bibr" rid="B16 B17 B18">16&#x02013;18</xref>). Agris and Brown (<xref ref-type="bibr" rid="B19">19</xref>) have identified key interactions between modified nucleosides and magnesium ions essential to the secondary structure of tRNA, in addition to facilitating key RNA&#x02013;protein interactions. Mandal <italic>et al</italic>. (<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>) have characterized binding of small molecules and metabolites to RNA motifs termed &#x02018;riboswitches&#x02019;. Riboswitches are structural motifs in mRNAs [sometimes in the 5&#x02032; untranslated region (UTR) and extending into the start of the open reading frame] that can exist in at least two stable conformations. One of these conformations is stabilized by binding to a small molecule, thus altering the equilibrium between the conformations. One conformation supports translation of the protein while with the other conformation, translation is blocked. In this way, binding of the small molecule changes the conformation of the RNA and modulates its translation. In addition to the 5&#x02032; UTR of prokaryotic mRNAs, riboswitches have also been found in the 3&#x02032; UTR and introns in several eukaryotic species (<xref ref-type="bibr" rid="B22">22</xref>). Interestingly, the Breaker lab has just reported the discovery of a riboswitch that responds to the queuine precursor, preQ<sub>1</sub> and appears to regulate the expression of the four genes that are involved in preQ<sub>1</sub> biosynthesis (<xref ref-type="bibr" rid="B23">23</xref>). It certainly seems possible that base modification of an mRNA could modulate a similar conformational change. It therefore is feasible that such a control mechanism for gene expression might be involved in regulating the expression of virulence factors in pathogenic organisms, as is apparently seen with VirF.</p><p>The incorporation of modified nucleosides has been characterized more fully for tRNA (and some other RNAs, e.g. rRNA and snRNA), than for mRNA (<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>). The most common example of post-transcriptional processing in mRNA is the eukaryotic 7-methylguanosine 5&#x02032; cap structure, which aids in the binding to the small ribosomal subunit and is essential for the efficient synthesis of eukaryotic proteins (<xref ref-type="bibr" rid="B26 B27 B28">26&#x02013;28</xref>). To date, the only known function of TGT is to catalyze the modification of tRNA with queuine. Previous work has shown that the eubacterial TGT will recognize a U-G-U sequence in the loop of an RNA hairpin structure that corresponds to the anticodon stem&#x02013;loop of its cognate tRNAs (<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>). The eubacterial TGT will also recognize a U-G-U containing hairpin in the context of a dimeric form of a cognate tRNA (<xref ref-type="bibr" rid="B31">31</xref>).</p><p>It is conceivable that an mRNA may also be modified directly by TGT, provided the mRNA contained the appropriate recognition elements. An examination of the sequence of <italic>virF</italic> mRNA for the presence of U-G-U sequences revealed six unique U-G-U sites (<xref ref-type="fig" rid="F3">Figure 3</xref>). Mfold analysis of the regions surrounding each of these U-G-U sequences reveal that nucleotides 410&#x02013;433 could possibly fold into a hairpin structure with the U-G-U sequence in a position in a loop that is analogous to the anticodon loop of TGT-cognate tRNAs. <fig id="F3" position="float"><label>Figure 3.</label><caption><p>Nucleotide sequence of <italic>virF</italic> mRNA. Six UGU sequences are found in the sequence, and are highlighted in red. The sequence of the <italic>virF</italic> MH is underlined.</p></caption><graphic xlink:href="gkm473f3"/></fig></p><p>As a first step towards probing the possibility that TGT may modulate the translation of VirF via modification of the <italic>virF</italic> mRNA, Michaelis&#x02013;Menten kinetic analyses were conducted to probe this modification by TGT <italic>in vitro</italic>. We report that the <italic>Escherichia coli</italic> TGT, which has 99% sequence identity to the <italic>S. flexneri</italic> TGT, does indeed recognize the <italic>virF</italic> mRNA as a substrate <italic>in vitro</italic>. Further, we show that this recognition results in the site-specific modification of a single base in the <italic>virF</italic> mRNA.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Reagents</title><p>Unless otherwise specified, all reagents were ordered from Sigma or Aldrich. DNA oligonucleotides, agarose, dithiothreitol (DTT), T4 DNA ligase and DNA ladders were ordered from Invitrogen. All restriction enzymes and Vent&#x000ae; DNA polymerase were ordered from New England Biolabs. The ribonucleic acid triphosphates (NTPs) and pyrophosphatase were ordered from Roche Applied Sciences. The deoxyribonucleic acid triphosphates (dNTPs) were ordered from Promega. Low-melting Seaplaque agarose was ordered from Cambrex. Gelase&#x02122; Enzyme Prep, MasterAmp&#x02122; High Fidelity RT&#x02013;PCR Kit, and Scriptguard&#x02122; RNase Inhibitor were ordered from Epicentre. Epicurian coli&#x000ae; XL2-Blue ultracompetent cells were ordered from Stratagene. Amicon Ultra Centrifugal Filter Devices were ordered from Millipore. Whatman GF/C Glass Microfibre Filters and all bacterial media components were ordered from Fisher. The QIAPrep&#x000ae; Spin Miniprep Kit was ordered from Qiagen. Tris&#x02013;HCl Buffer was ordered from Acros Organics. [<sup>3</sup>H] PreQ<sub>1</sub> was ordered from American Radiolabeled Chemicals, Inc. T7 RNA polymerase was isolated from <italic>E. coli</italic> BL21 cells containing the plasmid pBH161 according to the procedure of Prof. William McCallister, State University of New York, Brooklyn. The <italic>E. coli</italic> TGT was isolated with an amino terminal his-tag as previously described (<xref ref-type="bibr" rid="B32">32</xref>).</p></sec><sec><title>Synthesis of [<sup>3</sup>H] preQ<sub>1</sub> (<xref ref-type="fig" rid="F4">Figure 4</xref>)</title><p>The cyano precursor (preQ<sub>0</sub>, <bold>2</bold>) was synthesized according to the method of Migawa <italic>et al</italic>. (<xref ref-type="bibr" rid="B33">33</xref>) by the condensation of chloro(formyl)acetonitrile and pyrimidine <bold>1</bold> (<xref ref-type="bibr" rid="B33">33</xref>). Reduction of the cyano precursor with tritium gas gave the desired radiolabeled substrate preQ<sub>1</sub> (<bold>3</bold>) with a specific activity of 500&#x02009;mCi/mmol (<xref ref-type="bibr" rid="B34">34</xref>). The tritium reduction was performed commercially by American Radiolabeled Compounds Co. <fig id="F4" position="float"><label>Figure 4.</label><caption><p>Synthesis of radiolabeled [<sup>3</sup>H] preQ<sub>1</sub>. (<bold>A</bold>) chloro(formyl)acetonitrile, NaOAc, H<sub>2</sub>O, 100&#x000b0;C; (<bold>B</bold>) <sup>3</sup>H<sub>2</sub>, Pd/C, MeOH, 50&#x02009;psi.</p></caption><graphic xlink:href="gkm473f4"/></fig></p></sec><sec><title>Construction of pTZvirF</title><p>The plasmid pBDG302, containing the <italic>virf</italic> gene, was received from Prof. Glenn Bj&#x000f6;rk (Ume&#x000e5; University, Sweden). The <italic>virf</italic> gene was amplified from the plasmid by polymerase chain reaction (PCR) under the following conditions: primers (20&#x02009;pmol each), pBDG302 (500&#x02009;ng), Mg<sup>2+</sup> (2&#x02009;mM), dNTPs (1&#x02009;mM each), Vent DNA polymerase (4&#x02009;U), brought to a final volume of 50&#x02009;&#x003bc;l with deionized water. The sample was treated with 30 PCR cycles of the following sequence: 94&#x000b0;C (1&#x02009;min), 50&#x000b0;C (1&#x02009;min), and 72&#x000b0;C (2&#x02009;min), followed by a final extension at 72&#x000b0;C (5&#x02009;min). Following a double restriction enzyme digest with PstI and EcoRI (40&#x02009;U each, 20-&#x003bc;l reaction) for 1&#x02009;h at 37&#x000b0;C, the PCR product and vector were gel-purified from Seaplaque agarose with Gelase&#x02122; according to the vendor protocol. The purified <italic>virf</italic> gene was then ligated into digested pTZ19R<sup>Amp</sup> (5:1 volume ratio, 20&#x02009;&#x003bc;l reaction) following overnight incubation with T4 DNA ligase (2&#x02009;U) at 17&#x000b0;C. The ligated sample (10&#x02009;&#x003bc;l) was transformed into 100&#x02009;&#x003bc;l of Epicurian coli&#x000ae; XL2-Blue ultracompetent cells according to the Stratagene protocol. Cells were grown overnight at 37&#x000b0;C on L-Amp plates (50&#x02009;&#x003bc;g/ml ampicillin). Individual colonies were isolated, and 3&#x02009;mL 2xTY (16&#x02009;g Bactotryptone, 10&#x02009;g yeast extract, 5&#x02009;g NaCl/liter of water with 50&#x02009;&#x003bc;g/ml ampicillin) liquid cultures were inoculated at 37&#x000b0;C with shaking. Plasmid was isolated via miniprep, and the <italic>virf</italic> gene sequence was confirmed with DNA sequencing (University of Michigan DNA Sequencing Core Facilities).</p></sec><sec><title><italic>In vitro</italic> transcription</title><p><italic>In vitro</italic> transcription reactions with pTZvirF were conducted by first linearizing the plasmid at the end of the <italic>virf</italic> sequence with the restriction enzyme EcoRI (40&#x02009;U/100&#x02009;&#x003bc;l DNA, 500&#x02009;&#x003bc;l reaction). The sample was ethanol precipitated at &#x02212;20&#x000b0;C, and the pellet was re-suspended in 250&#x02009;&#x003bc;l of deionized water. <italic>In vitro</italic> 1&#x02009;ml transcription conditions were as follows: pTZvirF template (100&#x02009;&#x003bc;l), transcription buffer (4&#x02009;mM Tris&#x02013;HCl, pH 8.0; 2&#x02009;mM MgCl<sub>2</sub>, 0.5&#x02009;mM DTT, 0.1&#x02009;mM spermidine), NTPs (4&#x02009;mM each), T7 RNA polymerase (2500&#x02009;U), inorganic pyrophosphatase (2&#x02009;U) and RNase inhibitor (200&#x02009;U). The reaction was incubated at 37&#x000b0;C for &#x0223c;4&#x02009;h. The reaction was stored at &#x02212;20&#x000b0;C following transcription. Best results were obtained when the 1&#x02009;ml reaction was prepared and redistributed into 100&#x02009;&#x003bc;l volumes prior to incubation at 37&#x000b0;C. The MasterAmp &#x02122; High Fidelity RT&#x02013;PCR Kit was used according to vendor protocol to generate <italic>virf</italic> DNA, which was confirmed with sequence analysis of the DNA product (<xref ref-type="fig" rid="F5">Figure 5</xref>). <fig id="F5" position="float"><label>Figure 5.</label><caption><p>Transcription of <italic>virF</italic> mRNA. (<bold>A</bold>) <italic>In vitro</italic> transcription of <italic>virF</italic> mRNA visualized with ethidium bromide on a 1% TAE agarose gel. The single-stranded mRNA ran at &#x0223c;500&#x02009;bp in comparison to the 100-bp DNA ladder (lane 1). Lane 2: <italic>virF</italic> mRNA from a previous transcription reaction. Lanes 4 and 5: <italic>virF</italic> mRNA from replicate transcription reactions. (<bold>B</bold>) RT&#x02013;PCR samples visualized with ethidium bromide on a 1% TAE agarose gel. RT&#x02013;PCR was conducted using extracted mRNA from replicate samples (lanes 2 and 3), electrophoresed in comparison to a 100&#x02009;bp DNA ladder (lane 1). Each RNA sample produced the corresponding 800&#x02009;bp DNA species indicative of the <italic>virf</italic> ORF.</p></caption><graphic xlink:href="gkm473f5"/></fig></p></sec><sec><title>Mfold analysis and synthesis of <italic>virF</italic> MH</title><p>Analysis of the energetically favorable secondary structures within the <italic>virF</italic> mRNA sequence was performed using the biophysical web tool Mfold (M. Zuker, <ext-link ext-link-type="uri" xlink:href="http://bioweb.pasteur.fr/seqanal/interfaces/mfold-simple.html">http://bioweb.pasteur.fr/seqanal/interfaces/mfold-simple.html</ext-link>). Sequences of &#x0223c;10 nucleotides surrounding either side of the six possible recognition motifs were analyzed by the web tool, and the hairpin structure determined to be most favorable was found between nucleotides 410&#x02013;433 in the <italic>virF</italic> mRNA, which contains the potential recognition sequence U<sub>420</sub>G<sub>421</sub>U<sub>422</sub>. The RNAture Oligonucleotide Analyzer web tool was used to predict a Tm of 71&#x000b0;C for the <italic>virF</italic> minihelix hairpin. (Note: This web tool appears to be no longer available.) An Expedite&#x02122; Nucleic Acid Synthesis System was used to synthesize this 24-nucleotide sequence (5&#x02032;-GGAGUAGUCUUUGUCGACUAUUUU-3&#x02032;) using the vendor's protocols for the synthesis of RNA at the 1&#x02009;&#x003bc;mol scale. The reagents were from Perkin&#x02013;Elmer and the RNA amidites were from Glen Research. The extinction coefficient calculated for this RNA minihelix was &#x003b5;<sub>260</sub> = 265.3&#x02009;OD/mM.</p></sec><sec><title>Generation of <italic>virF</italic> mRNA(G<sub>421</sub>A)</title><p>The single nucleotide mutation of guanine 421 to adenine in the <italic>virF</italic> mRNA sequence was generated via QuikChange site-directed mutagenesis (Stratagene), producing the new vector pTZvirF(G<sub>421</sub>A). The reactions conditions were as follows: complimentary oligonucleotides with desired mutation (175&#x02009;ng), pTZvirF(wt) template (800&#x02009;ng), dNTPs (0.25&#x02009;mM) and Vent DNA polymerase (2&#x02009;U), brought to a final volume of 30&#x02009;&#x003bc;l with deionized water. The sample was treated with 25 PCR cycles of the following sequence: 94&#x000b0;C (30&#x02009;s), 50&#x000b0;C (1&#x02009;min), and 72&#x000b0;C (6.5&#x02009;min). The PCR product was then incubated for 2&#x02009;h at 37&#x000b0;C with Dpn I (40&#x02009;U), and addition of NE Buffer 4 was required for proper digestion of wild-type plasmid. The digested sample (10&#x02009;&#x003bc;l) was transformed into 100&#x02009;&#x003bc;l of Epicurian coli&#x000ae; XL2-Blue ultracompetent cells according to the Stratagene protocol. Cells were grown overnight at 37&#x000b0;C on L-Amp plates (50&#x02009;&#x003bc;g/ml ampicillin). Individual colonies were isolated, and 3&#x02009;ml 2xTY (16&#x02009;g bactotryptone, 10&#x02009;g yeast extract, 5&#x02009;g NaCl/liter of water with 50&#x02009;&#x003bc;g/ml ampicillin) liquid cultures were inoculated at 37&#x000b0;C with shaking. Plasmid was isolated via miniprep, and the <italic>virF</italic> mRNA(G<sub>421</sub>A) mutation was confirmed with DNA sequencing (University of Michigan DNA Sequencing Core Facilities).</p></sec><sec><title>Kinetic assays</title><p>Assays were conducted by monitoring the incorporation of radiolabeled substrate, [<sup>3</sup>H] preQ<sub>1</sub>, into <italic>E. coli</italic> tRNA<sup>Tyr</sup>, dG<sub>34</sub>ECYMH (5&#x02032;-GGGAGCAGACUdGUAAAUCUGCUCCC-3&#x02032;) and various <italic>virF</italic> mRNA substrates. Samples from <italic>in vitro</italic> transcriptions were concentrated with Amicon Ultra Centrifugal Filters (10,000 MWCO). The concentration of <italic>virF</italic> mRNA was determined with a Cary UV-Visible Spectrophotometer, where the approximate concentration of a single-stranded RNA sample A<sub>260</sub> = 1 OD is 40&#x02009;&#x003bc;g/ml and the molecular weight of <italic>virF</italic> mRNA is 252&#x02009;g/mmol <italic>virF</italic> mRNA. In brief, kinetic assays were set up under the following conditions: RNA substrate (various concentrations), [<sup>3</sup>H] preQ<sub>1</sub> (10&#x02009;&#x003bc;M, 296mCi/mmol stock), TGT (100 or 200&#x02009;nM, as specified), and HEPES reaction buffer (100&#x02009;mM HEPES, pH 7.3; 20&#x02009;mM MgCl<sub>2</sub>; 5&#x02009;mM DTT) to a final volume of 400&#x02009;&#x003bc;l. All samples were incubated at 37&#x000b0;C for purposes of equilibration before initiating the reaction with the addition of TGT. Aliquots (70&#x02009;&#x003bc;l) were removed at various points throughout the reaction and quenched in 3&#x02009;ml of 5% TCA for 1&#x02009;h before filtering on glass-fiber filters. Each filter was washed with three volumes of 5% TCA and a final wash of ethanol to dry the filter. The samples were analyzed in a scintillation counter (Beckman) for radioactive decay, where counts were reported in DPM and later converted to picomoles [<sup>3</sup>H] preQ<sub>1</sub> by the following conversion (pmol = DPM &#x000d7; 0.00152, for the [<sup>3</sup>H] preQ<sub>1</sub> stock with a specific activity of 296&#x02009;mCi/mmol). Initial velocities were determined by converting the slopes of these plots (pmol/min) to units of second<sup>&#x02212;1</sup>, taking into account the concentration of the enzyme and aliquot size. The individual data points from each trial were averaged, and the standard deviation was determined for each concentration of RNA substrate. The average data points (with error bars representing their standard deviations) were plotted. However, all of the individual data points were fit via non-linear regression to the Michaelis&#x02013;Menten equation and the line for that fit is displayed (<xref ref-type="fig" rid="F6">Figure 6</xref>). All non-linear regression fits with the Michaelis&#x02013;Menten equation were determined using Kaleidagraph (Abelbeck Software). <fig id="F6" position="float"><label>Figure 6.</label><caption><p>Kinetic characterization of <italic>virF</italic> mRNA substrates with <italic>E. coli</italic> TGT and [<sup>3</sup>H] preQ<sub>1</sub>. (<bold>A</bold>) and (<bold>B</bold>) The individual data points were fit to the Michaelis&#x02013;Menten equation by non-linear regression, and the average data points (with error bars representing the standard deviations of the averages) for each concentration of RNA substrate are depicted. The study was performed with duplicate kinetic trials at saturating concentrations of [<sup>3</sup>H] preQ<sub>1</sub>. The inset in B shows the structure of the RNA minihelix corresponding to bases 410&#x02013;433 of the <italic>virF</italic> mRNA. (<bold>C</bold>) The comparison of radioactive substrate incorporated over time in <italic>virF</italic> mRNA(wt) (blue, squares and diamonds), <italic>virF</italic> mRNA(G<sub>421</sub>A) (green, crosses and triangles), and a no RNA control (red, circles), fit by linear regression. Each <italic>virF</italic> mRNA substrate was analyzed at two concentrations: 2&#x02009;&#x003bc;M (squares and crosses) and 10&#x02009;&#x003bc;M (diamonds and triangles). The average of duplicate trials is shown.</p></caption><graphic xlink:href="gkm473f6"/></fig></p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Construction and <italic>in vitro</italic> transcription of pTZvirF</title><p>To provide micromolar quantities of <italic>virF</italic> mRNA for our studies, we generated an <italic>in vitro</italic> transcription clone for the <italic>virF</italic> mRNA. The <italic>virf</italic> gene was subcloned from the plasmid pBDG302 containing the <italic>virf</italic> gene (a gift from Professor Glenn Bj&#x000f6;rk, Ume&#x000e5; University, Sweden) into a plasmid suitable for <italic>in vitro</italic> transcription, generating pTZvirF. <italic>VirF</italic> mRNA was synthesized via <italic>in vitro</italic> run-off transcription following digestion with EcoRI, linearizing pTZvirF at the end of the <italic>virf</italic> gene sequence. The <italic>virF</italic> mRNA was physically characterized on an ethidium bromide stained, 1.2% formaldehyde agarose gel.RT&#x02013;PCR was utilized to generate dsDNA from the <italic>in vitro</italic> transcription product using the same oligonucleotide primers initially designed for subcloning of the <italic>virf</italic> gene. Examples of formaldehyde and TAE agarose gels of the <italic>virF</italic> mRNA and the dsDNA from the RT&#x02013;PCR are shown in <xref ref-type="fig" rid="F5">Figure 5</xref>.</p><p>The single-stranded <italic>virF</italic> mRNA appears to run on the gel at &#x0223c;500&#x02009;bp in comparison to the dsDNA ladder. The size of the <italic>virf</italic> gene is 789&#x02009;bp, and the corresponding mRNA is 789 nucleotides in length. We hypothesize that the mRNA is running at a lower &#x02018;apparent&#x02019; molecular weight due to the propensity of mRNA to adopt a variety of conformations, even in an agarose gel. This would explain why the observed molecular weight is a little larger than one half the size of the double-stranded <italic>virf</italic> DNA. The RT&#x02013;PCR product (dsDNA) migrated to the anticipated molecular weight for a DNA sample of &#x0223c;800&#x02009;bp. DNA sequencing of this product matched the <italic>virF</italic> mRNA sequence (data not shown).</p></sec><sec><title>Kinetic analysis of <italic>E. coli</italic> tRNA<sup>Tyr</sup>, ECYMH minihelix with preQ<sub>1</sub></title><p>For comparison, Michaelis&#x02013;Menten kinetic analyses were conducted with the natural RNA substrate <italic>E. coli</italic> tRNA<sup>Tyr</sup> (ECY) and the modified minihelix substrate dG<sub>34</sub>ECYMH (the anticodon stem&#x02013;loop of ECY where the guanosine at position 34 contains a 2&#x02032;-deoxyribose) with [<sup>3</sup>H] preQ<sub>1</sub>. It has been shown previously that a minihelix RNA consisting of the anticodon arm and loop of a queuine-cognate tRNA is a sufficient substrate for TGT (<xref ref-type="bibr" rid="B29">29</xref>). Aliquots were taken at various time points over a 15&#x02009;min incubation of 100&#x02009;nM <italic>E. coli</italic> TGT, various concentrations of ECY (0.05&#x02013;1.5&#x02009;&#x003bc;M) or dG<sub>34</sub>ECYMH (0.05&#x02013;5&#x02009;&#x003bc;M) and saturating concentrations of [<sup>3</sup>H] preQ<sub>1</sub>. The kinetic constants determined for the incorporation of [<sup>3</sup>H] preQ<sub>1</sub> with ECY and dG<sub>34</sub>ECYMH are shown in comparison with the kinetic data for the <italic>virF</italic> substrates in <xref ref-type="table" rid="T1">Table 1</xref>. <table-wrap id="T1" position="float"><label>Table 1.</label><caption><p>RNA kinetic parameters with <italic>E. coli</italic> htTGT(wt) and [<sup>3</sup>H] preQ1&#x02009;at pH 7.3</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"><italic>K<sub>M</sub></italic> (&#x003bc;M)</th><th rowspan="1" colspan="1"><italic>k<sub>cat</sub></italic> (10<sup>&#x02212;4</sup> s<sup>&#x02212;1</sup>)</th><th rowspan="1" colspan="1"><italic>k<sub>cat/</sub>K<sub>M</sub></italic> (10<sup>2</sup> M<sup>&#x02212;1</sup> s<sup>&#x02212;1</sup>)</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">ECY</td><td rowspan="1" colspan="1">0.16 (0.03)<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">40 (2)</td><td rowspan="1" colspan="1">250 (40)</td></tr><tr><td rowspan="1" colspan="1">dG<sub>34</sub>ECYMH</td><td rowspan="1" colspan="1">0.26 (0.07)</td><td rowspan="1" colspan="1">70 (5)</td><td rowspan="1" colspan="1">270 (60)</td></tr><tr><td rowspan="1" colspan="1"><italic>virF</italic> mRNA</td><td rowspan="1" colspan="1">1.8 (0.4)</td><td rowspan="1" colspan="1">1.1 (0.1)</td><td rowspan="1" colspan="1">0.60 (0.1)</td></tr><tr><td rowspan="1" colspan="1"><italic>virF</italic> MH</td><td rowspan="1" colspan="1">0.87 (0.3)</td><td rowspan="1" colspan="1">3.3 (0.3)</td><td rowspan="1" colspan="1">3.8 (1)</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p><sup>a</sup>Standard errors are in parentheses.</p></fn></table-wrap-foot></table-wrap></p></sec><sec><title>Kinetic analysis of <italic>virF</italic> mRNA, <italic>virF</italic> MH minihelix with preQ<sub>1</sub></title><p>Using the same approach described above, Michaelis&#x02013;Menten kinetic analyses were conducted with <italic>virF</italic> mRNA. Aliquots were taken at various time points over a 1&#x02009;h incubation of 200&#x02009;nM TGT, various concentrations of <italic>virF</italic> mRNA (0.1&#x02013;10&#x02009;&#x003bc;M), and saturating concentrations of [<sup>3</sup>H] preQ<sub>1</sub> (<xref ref-type="fig" rid="F6">Figure 6</xref>A). Higher concentrations of <italic>virF</italic> mRNA were tested to obtain an accurate kinetic profile by characterizing the reaction over a large range of concentrations. In addition to characterizing the wild-type <italic>virF</italic> mRNA, a <italic>virF</italic> minihelix RNA (<italic>virF</italic> MH) corresponding to the 410&#x02013;433 hairpin sequence (underlined in <xref ref-type="fig" rid="F3">Figure 3</xref>) as well as a full-length <italic>virF</italic> mRNA mutant (G<sub>421</sub>A) were studied. The kinetic analyses were performed with 100&#x02009;nM <italic>E. coli</italic> TGT, various concentrations of <italic>virF</italic> MH (0.1&#x02013;10&#x02009;&#x003bc;M) and saturating concentrations of [<sup>3</sup>H] preQ<sub>1</sub> (<xref ref-type="fig" rid="F6">Figure 6</xref>B). The full-length <italic>virF</italic> mRNA(G<sub>421</sub>A) was incubated under the same conditions as the wild-type mRNA, but only at concentrations corresponding to <italic>K<sub>M</sub></italic> and 5x<italic>K<sub>M</sub></italic>, as determined from the kinetic constants of <italic>virF</italic> mRNA(wt) (<xref ref-type="table" rid="T1">Table 1</xref>). A &#x02018;no RNA&#x02019; control was also included to determine the background level of radioactivity present in the samples (<xref ref-type="fig" rid="F6">Figure 6</xref>C). The data were fit by non-linear regression.</p><p>Both the full-length <italic>virF</italic> mRNA(wt) and the <italic>virF</italic> minihelix exhibited RNA concentration-dependent incorporation of [<sup>3</sup>H] preQ<sub>1</sub> over time, and the Michaelis&#x02013;Menten equation provided a good fit for the data. The full-length <italic>virF</italic> mRNA(G<sub>421</sub>A), which is full-length mRNA with a single nucleotide mutation at guanine 421, was analyzed at both 2&#x02009;&#x003bc;M (&#x0223c;<italic>K<sub>M</sub></italic>) and 10&#x02009;&#x003bc;M (&#x0223c;5 &#x000d7; <italic>K<sub>M</sub></italic>) mRNA. The <italic>virF</italic> mRNA(G<sub>421</sub>A) mutant showed no detectable activity greater than the &#x02018;no RNA&#x02019; control (<xref ref-type="fig" rid="F6">Figure 6</xref>C). The kinetic constants determined for the <italic>virF</italic> mRNA substrates are shown in <xref ref-type="table" rid="T1">Table 1</xref>.</p><p>Both the <italic>virF</italic> mRNA and <italic>virF</italic> MH have <italic>K<sub>M</sub></italic> values in the low micromolar range, even though <italic>k<sub>cat</sub></italic> and <italic>k<sub>cat</sub>/K<sub>M</sub></italic> for both is lower than the corresponding values for the ECY substrates.</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>VirF is a critical transcriptional regulator responsible for activating virulence genes in <italic>Shigella flexneri</italic>. Durand and colleagues (<xref ref-type="bibr" rid="B35">35</xref>) demonstrated the involvement of TGT in modulating the translation of VirF via the observation that a mutant strain of <italic>Shigella</italic> with an inactivated <italic>tgt</italic> gene (termed <italic>vacC)</italic> showed decreased virulence. VirF protein levels were dramatically lower in the mutant as compared to wild-type, but the <italic>virF</italic> mRNA levels showed no detectable difference from wild-type <italic>Shigella</italic>. The lack of VirF protein resulted in a reduction of all downstream virulence gene expression, and thus exhibited a less virulent phenotype than that of the wild-type bacterium. When transformed with a plasmid encoding the <italic>Shigella tgt</italic> gene, both VirF translation and virulence were restored. It had previously been shown that the presence of modified nucleosides enhances translation (<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref>). However, other studies have shown that growth rate and protein translation as a whole are not directly affected by a lack of queuine-modified tRNA (<xref ref-type="bibr" rid="B38">38</xref>). While this interesting correlation between VirF translation and TGT activity has been known for some time, yet the exact role TGT plays in the translation of this primary virulence factor remains unclear.</p><p>Our laboratory has previously demonstrated that TGT can modify substrates with more unusual structures than a canonical tRNA fold. We reported that a dimeric form of the ECY serves as a substrate for TGT, with a slightly higher <italic>K<sub>M</sub></italic> and identical <italic>k<sub>cat</sub></italic>, relative to the normal tRNA (<xref ref-type="bibr" rid="B31">31</xref>). It had previously been shown from NMR studies that the anticodon arms of the dimer subunits were intact and pointing away from the center of the dimer (<xref ref-type="bibr" rid="B39">39</xref>).</p><p>Those studies demonstrate that TGT can recognize a minihelix containing the requisite U-G-U sequence even in the context of a larger RNA structure. TGT is not the first tRNA modification enzyme to demonstrate recognition of alternative RNA structures. Gu and coworkers (<xref ref-type="bibr" rid="B24">24</xref>) have shown that, <italic>in vitro</italic>, the modification enzyme tRNA (m<sup>5</sup>U54)-methyltransferase will methylate 16S ribosomal RNA from <italic>E. coli</italic> in addition to its physiological tRNA substrate, although they found no evidence for this occurring <italic>in vivo</italic>. The enzyme pseudouridine synthase catalyzes the isomerization of specific uridines to the modified nucleoside &#x003c8;. A single pseudouridine synthase has been shown to have &#x02018;dual specificity&#x02019;, recognizing and modifying both tRNA and snRNA (<xref ref-type="bibr" rid="B40 B41 B42">40&#x02013;42</xref>). Ofengand and colleagues (<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B44">44</xref>) have also characterized a critical pseudouridine synthase responsible for site-specific modification with pseudouridine <italic>in vivo</italic> for both tRNA and 23S&#x02009;rRNA in <italic>E. coli</italic>. Such precedence for tRNA modification enzymes to recognize and modify other RNA species <italic>in vitro</italic> and <italic>in vivo</italic>, suggests that <italic>virF</italic> mRNA modification mediated by TGT may also occur. As a first step to probe for this possibility, we examined the <italic>virF</italic> mRNA sequence for the presence of a U-G-U sequence in a TGT recognition motif. Of the six U-G-U sequences in the <italic>virF</italic> mRNA, the one involving bases 410&#x02013;433 (<xref ref-type="fig" rid="F3">Figure 3</xref>) was predicted by Mfold analysis to be able to fold into a hairpin structure possibly suitable for recognition by TGT.</p><p>Incubation of <italic>virF</italic> mRNA with <italic>E. coli</italic> TGT and radiolabeled preQ<sub>1</sub> revealed that the <italic>virF</italic> mRNA is indeed a substrate for TGT <italic>in vitro</italic>. The kinetic parameters (<italic>K<sub>M</sub>, k<sub>cat</sub></italic>; <xref ref-type="table" rid="T1">Table 1</xref>) for <italic>virF</italic> mRNA were determined from a Michaelis&#x02013;Menten analysis (<xref ref-type="fig" rid="F6">Figure 6</xref>A). The <italic>virF</italic> mRNA substrates exhibit the same trend in kinetic parameters as the ECY substrates, where the minihelix substrates (dG<sub>34</sub>ECYMH and <italic>virF</italic> MH) have slightly higher values for both <italic>K<sub>M</sub></italic> and <italic>k<sub>cat</sub>/K<sub>M</sub></italic> with respect to the corresponding full-length RNA substrates (<xref ref-type="table" rid="T1">Table 1</xref>). The values of <italic>K<sub>M</sub></italic> for both ECY and <italic>virF</italic> mRNA are very similar, both in the low micromolar range. This is encouraging considering the size and structural difference between the two substrates, where ECY is &#x0223c;80 nucleotides in length with a very well-defined tertiary structure common to tRNA and the <italic>virF</italic> mRNA is <italic>ca</italic>. 800 nucleotides in length and presumably does not have a compact tertiary structure. The Michaelis&#x02013;Menten plot for the <italic>virF</italic> mRNA (<xref ref-type="fig" rid="F6">Figure 6</xref>A) fits to a single <italic>K<sub>M</sub></italic>, consistent with a single site of modification within the <italic>virF</italic> mRNA. The <italic>k<sub>cat</sub></italic> for the <italic>virF</italic> mRNA is &#x0223c; 40-fold lower than that for tRNA. It has previously been shown that altering the position of the U-G-U sequence within the minihelix loop of cognate tRNAs is correlated with a reduction in activity (<xref ref-type="bibr" rid="B45">45</xref>). All of the biochemical and structural data previously reported is consistent with a covalent intermediate, via Asp264, in the TGT reaction (<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B46 B47 B48">46&#x02013;48</xref>). The hairpin loop of the ECY substrate contains seven nucleotides, whereas the hairpin in the <italic>virF</italic> mRNA substrate contains only six nucleotides in the loop. This difference in loop length may result in a suboptimal orientation of the guanosine ribose in the U<sub>420</sub>-G<sub>421</sub>-U<sub>422</sub> loop in the <italic>virF</italic> mRNA, making nucleophilic attack by Asp264 less likely. This difference in loop length and orientation could account for the reduced <italic>k<sub>cat</sub></italic> that we have observed for the <italic>virF</italic> mRNA substrates.</p><p>Our analysis of the <italic>virF</italic> mRNA sequence predicts that there should be a single site of modification, guanine 421. We have taken two approaches to investigate this. In our first approach, a <italic>virF</italic> MH corresponding to the predicted hairpin structure within the native <italic>virF</italic> mRNA sequence (bases 410&#x02013;433), was chemically synthesized (<xref ref-type="fig" rid="F6">Figure 6</xref>B). The stem consists of nine base pairs, where the first four nucleotides in the stem are uridine residues forming wobble pair interactions with three guanines and one Watson&#x02013;Crick pair with an adenosine. At first glance, the stability of a minihelix with three G-U wobble pairs might be questionable; however, in the context of the <italic>virF</italic> mRNA, the ends of the helix may be held in close proximity by other intramolecular interactions. Additionally, the <italic>virF</italic> MH by itself has a predicted melting temperature of 71&#x000b0;C, indicating the structure should be stable at physiological and assay temperatures. The <italic>virF</italic> MH is a substrate for TGT <italic>in vitro</italic>. The <italic>K<sub>M</sub></italic> values for both the full-length <italic>virF</italic> mRNA and <italic>virF</italic> MH (1.8 and 0.87&#x02009;&#x003bc;M, respectively; <xref ref-type="table" rid="T1">Table 1</xref>) are very similar, suggesting that the minihelix structure is likely a predominant conformation in the <italic>virF</italic> mRNA.</p><p>Although the recognition of the <italic>virF</italic> minihelix by TGT is consistent with the <italic>virF</italic> mRNA serving as a substrate for TGT, it does not provide conclusive evidence that guanine 421 is the site of modification in the <italic>virF</italic> mRNA. There are six UGU sequences within the <italic>virF</italic> mRNA that are possible recognition sites for TGT. Therefore, our second approach was to construct the point mutation, G<sub>421</sub>A, in the full-length <italic>virF</italic> mRNA to demonstrate the importance of guanine 421. The <italic>virF</italic> mRNA(G<sub>421</sub>A) mutant resulted in a complete loss of activity at two different concentrations of RNA (<xref ref-type="fig" rid="F6">Figure 6</xref>C), indicating that G<sub>421</sub> is indeed essential for recognition by TGT. Had a second exchangeable guanine existed in the sequence, we would have expected to see a decreased or possibly even unchanged activity of the mRNA. The relationship between the &#x02018;no RNA&#x02019; negative control and the <italic>virF</italic> mRNA(G<sub>421</sub>A) indicates that guanine 421 is the only exchangeable nucleotide in the <italic>virF</italic> mRNA sequence (at least within the concentration ranges tested), and that the kinetic parameters observed for <italic>virF</italic> mRNA(wt) are due to specific recognition by TGT and could not be attributed to non-specific interactions with this large nucleic acid molecule. It should be noted that, under the conditions of the assay (<xref ref-type="fig" rid="F6">Figure 6</xref>C), it appears that the enzyme is undergoing a limited number of turnovers. Two factors may be contributing to this. The first is that our calculations of kinetic parameters assume 100% active enzyme, which is almost certainly an over-estimate. The active enzyme concentration may be as much as 2-fold lower as recent studies suggest that the eubacterial TGT may exist as a homodimer with &#x02018;half-of-sites&#x02019; reactivity (<xref ref-type="bibr" rid="B49">49</xref>). This would effectively double the turnovers per active site. Second, the off-rate for the modified mRNA may be sufficiently slower (relative to that for tRNA) such that the turnover rate may indeed be significantly slowed under these conditions. It remains to be seen if these observations hold under <italic>in vivo</italic> conditions.</p><p>From the results presented herein, it is clear that the <italic>virF</italic> mRNA does act as a substrate for the eubacterial TGT <italic>in vitro</italic>. Although there are six possible UGU recognition motifs, both the mutagenesis and <italic>virF</italic> mRNA minihelix studies are consistent with G<sub>421</sub> serving as the sole site of modification within the mRNA. With a <italic>K<sub>M</sub></italic> value in the low micromolar range, it is very possible that the modification of <italic>virF</italic> mRNA may be biologically relevant (e.g. may occur <italic>in vivo</italic>). These results provide the first &#x02018;proof of principle&#x02019; evidence that post-transcriptional RNA modification may regulate mRNA function, as it has long been recognized to do for tRNA. The recent work characterizing the preQ<sub>1</sub> riboswitch revealed that it is a fairly simple hairpin structure (the simplest riboswitch structure characterized to date) (<xref ref-type="bibr" rid="B23">23</xref>). Such a simple structure could feasibly occur in the coding region of an mRNA species. In fact, the TGT modification site that we have discovered in the <italic>virF</italic> mRNA is predicted to occur in a simple hairpin structural motif. Base modification in a hairpin structure in the coding sequence of <italic>virF</italic> mRNA could induce a similar structural switch as seen in the preQ<sub>1</sub> riboswitch and thereby influence translation of VirF. Studies to determine the physiological significance of the <italic>virF</italic> mRNA modification by TGT that we have observed <italic>in vitro</italic> are currently in progress.</p></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>We gratefully acknowledge Professor Glenn Bj&#x000f6;rk for the plasmid pBDG302 containing the <italic>virf</italic> gene. We thank Dr Ruth Brenk for use of her figure illustrating <italic>Shigella</italic> pathogenesis (<xref ref-type="fig" rid="F2">Figure 2</xref>) and members of the Garcia laboratory for critical review of this manuscript. This research was supported by National Institutes of Health (GM065489 to G.A.G. and GM07767&#x02009;J.K.H. trainee) and the University of Michigan, College of Pharmacy.</p><p>Funding to pay the Open Access publication charges for this article was provided by Oxford University Press.</p><p><italic>Conflict of interest statement</italic>. None declared.</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Limbach</surname><given-names>PA</given-names></name><name><surname>Crain</surname><given-names>PF</given-names></name><name><surname>McCloskey</surname><given-names>JA</given-names></name></person-group><article-title>Summary: the modified nucleosides of RNA</article-title><source>Nucleic Acids Res</source><year>1994</year><volume>22</volume><fpage>2183</fpage><lpage>2196</lpage><pub-id pub-id-type="pmid">7518580</pub-id></citation></ref><ref id="B2"><label>2</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>GA</given-names></name><name><surname>Goodenough-Lashua</surname><given-names>DM</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Grosjean</surname><given-names>H</given-names></name><name><surname>Benne</surname><given-names>R</given-names></name></person-group><source>Modification and Editing of RNA</source><year>1998</year><publisher-loc>Washington, DC</publisher-loc><publisher-name>ASM Press</publisher-name><fpage>135</fpage><lpage>168</lpage></citation></ref><ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adamiak</surname><given-names>RW</given-names></name><name><surname>Gornicki</surname><given-names>D</given-names></name></person-group><article-title>Hypermodified nucleosides of tRNA: synthesis, chemistry, and structural features of biological interest</article-title><source>Prog. Nucleic Acid Res. Mol. Biol</source><year>1985</year><volume>32</volume><fpage>27</fpage><pub-id pub-id-type="pmid">3911278</pub-id></citation></ref><ref id="B4"><label>4</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Grosjean</surname><given-names>H</given-names></name><name><surname>Benne</surname><given-names>R</given-names></name></person-group><source>Modification and Editing of RNA: The Alteration of RNA Structure and Function</source><year>1998</year><publisher-loc>Washington, D.C</publisher-loc><publisher-name>ASM Press</publisher-name></citation></ref><ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grosjean</surname><given-names>H</given-names></name><name><surname>Sprinzl</surname><given-names>M</given-names></name><name><surname>Steinberg</surname><given-names>S</given-names></name></person-group><article-title>Posttranscriptionally modified nucleosides in transfer RNA: Their locations and frequencies</article-title><source>Biochimie</source><year>1995</year><volume>77</volume><fpage>139</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">7541252</pub-id></citation></ref><ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harada</surname><given-names>F</given-names></name><name><surname>Nishimura</surname><given-names>S</given-names></name></person-group><article-title>Possible anticodon sequences of tRNA<sup>His</sup>, tRNA<sup>Asn</sup>, and tRNA<sup>Asp</sup> from <italic>Escherichia coli</italic> B. Universal presence of nucleoside Q in the first position of the anticodons of these transfer ribonucleic acids</article-title><source>Biochemistry</source><year>1972</year><volume>11</volume><fpage>301</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">4550561</pub-id></citation></ref><ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reader</surname><given-names>JS</given-names></name><name><surname>Metzgar</surname><given-names>D</given-names></name><name><surname>Schimmel</surname><given-names>P</given-names></name><name><surname>de Crecy-Lagard</surname><given-names>V</given-names></name></person-group><article-title>Identification of four genes necessary for biosynthesis of the modified nucleoside queuosine</article-title><source>J. Biol. Chem</source><year>2004</year><volume>279</volume><fpage>6280</fpage><pub-id pub-id-type="pmid">14660578</pub-id></citation></ref><ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Slany</surname><given-names>RK</given-names></name><name><surname>Kersten</surname><given-names>H</given-names></name></person-group><article-title>Genes, enzymes and coenzymes of queuosine biosynthesis in procaryotes</article-title><source>Biochimie</source><year>1994</year><volume>76</volume><fpage>1178</fpage><lpage>1182</lpage><pub-id pub-id-type="pmid">7748953</pub-id></citation></ref><ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reyniers</surname><given-names>JP</given-names></name><name><surname>Pleasants</surname><given-names>JR</given-names></name><name><surname>Wostmann</surname><given-names>BS</given-names></name><name><surname>Katze</surname><given-names>JR</given-names></name><name><surname>Farkas</surname><given-names>WR</given-names></name></person-group><article-title>Administration of exogenous queuine is essential for the biosynthesis of the queuosine-containing trnasfer RNAs in the mouse</article-title><source>J. Biol. Chem</source><year>1981</year><volume>206</volume><fpage>11591</fpage><lpage>11594</lpage><pub-id pub-id-type="pmid">6795188</pub-id></citation></ref><ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gunduz</surname><given-names>U</given-names></name><name><surname>Katze</surname><given-names>JR</given-names></name></person-group><article-title>Queuine salvage in mammalian cells</article-title><source>J. Biol. Chem</source><year>1984</year><volume>259</volume><fpage>1110</fpage><lpage>1113</lpage><pub-id pub-id-type="pmid">6319378</pub-id></citation></ref><ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Durand</surname><given-names>JMB</given-names></name><name><surname>Bjork</surname><given-names>GR</given-names></name></person-group><article-title>Putrescine or a combination of methionine and arginine restores virulence gene expression in a tRNA modification-deficient mutant of <italic>Shigelia flexneri</italic>: a possible role in adaptation of virulence</article-title><source>Mol. Microbiol</source><year>2003</year><volume>47</volume><fpage>519</fpage><lpage>527</lpage><pub-id pub-id-type="pmid">12519201</pub-id></citation></ref><ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dorman</surname><given-names>CJ</given-names></name><name><surname>Porter</surname><given-names>ME</given-names></name></person-group><article-title>The Shigella virulence gene regulatory cascade: a paradigm of bacterial gene control mechanisms</article-title><source>Mol. Microbiol</source><year>1998</year><volume>29</volume><fpage>677</fpage><lpage>684</lpage><pub-id pub-id-type="pmid">9723908</pub-id></citation></ref><ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jost</surname><given-names>BH</given-names></name><name><surname>Adler</surname><given-names>B</given-names></name></person-group><article-title>Site of transcriptional activation of virB on the large plasmid of <italic>Shigella flexneri</italic> 2a by VirF, a member of the AraC family of transcriptional activators</article-title><source>Microb. Pathog</source><year>1993</year><volume>14</volume><fpage>481</fpage><lpage>488</lpage><pub-id pub-id-type="pmid">8412620</pub-id></citation></ref><ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tobe</surname><given-names>T</given-names></name><name><surname>Yoshikawa</surname><given-names>M</given-names></name><name><surname>Mizuno</surname><given-names>T</given-names></name><name><surname>Sasakawa</surname><given-names>C</given-names></name></person-group><article-title>Transcriptional control of the invasion regulatory gene virB of <italic>Shigella flexneri</italic>: activation by virF and repression by H-NS</article-title><source>J. Bacteriol</source><year>1993</year><volume>175</volume><fpage>6142</fpage><lpage>6149</lpage><pub-id pub-id-type="pmid">7691791</pub-id></citation></ref><ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Durand</surname><given-names>JM</given-names></name><name><surname>Dagberg</surname><given-names>B</given-names></name><name><surname>Uhlin</surname><given-names>BE</given-names></name><name><surname>Bjork</surname><given-names>GR</given-names></name></person-group><article-title>Transfer RNA modification, temperature and DNA superhelicity have a common target in the regulatory network of the virulence of <italic>Shigella flexneri</italic>: the expression of the virF gene</article-title><source>Mol. Microbiol</source><year>2000</year><volume>35</volume><fpage>924</fpage><lpage>935</lpage><pub-id pub-id-type="pmid">10692168</pub-id></citation></ref><ref id="B16"><label>16</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Agris</surname><given-names>PF</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Cohn</surname><given-names>WE</given-names></name><name><surname>Moldave</surname><given-names>K</given-names></name></person-group><source>Progress in Nucleic Acid Research and Molecular Biology</source><year>1996</year><volume>53</volume><publisher-loc>San Diego, CA 92101-4495</publisher-loc><publisher-name>Academic Press Inc., 525 B Street, Suite 1900</publisher-name><fpage>79</fpage><lpage>129</lpage></citation></ref><ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Varani</surname><given-names>G</given-names></name><name><surname>Tinoco</surname><given-names>I</given-names></name></person-group><article-title>Rna Structure And Nmr-Spectroscopy</article-title><source>Q Rev Biophys</source><year>1991</year><volume>24</volume><fpage>479</fpage><pub-id pub-id-type="pmid">1723809</pub-id></citation></ref><ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heus</surname><given-names>HA</given-names></name><name><surname>Pardi</surname><given-names>A</given-names></name></person-group><article-title>Structural features that give rise to the unusual stability of RNA hairpins containing Gnra loops</article-title><source>Science</source><year>1991</year><volume>253</volume><fpage>191</fpage><pub-id pub-id-type="pmid">1712983</pub-id></citation></ref><ref id="B19"><label>19</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Agris</surname><given-names>PF</given-names></name><name><surname>Brown</surname><given-names>SC</given-names></name></person-group><person-group person-group-type="editor"><name><surname>James</surname><given-names>TL</given-names></name></person-group><source>Nuclear Magnetic Resonance and Nucleic Acids</source><year>1995</year><volume>261</volume><publisher-loc>San Diego, CA 92101-4495</publisher-loc><publisher-name>Academic Press Inc., 525 B Street, Suite 1900</publisher-name><fpage>270</fpage><lpage>299</lpage></citation></ref><ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrick</surname><given-names>JE</given-names></name><name><surname>Corbino</surname><given-names>KA</given-names></name><name><surname>Winkler</surname><given-names>WC</given-names></name><name><surname>Nahvi</surname><given-names>A</given-names></name><name><surname>Mandal</surname><given-names>M</given-names></name><name><surname>Collins</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Roth</surname><given-names>A</given-names></name><name><surname>Sudarsan</surname><given-names>N</given-names></name><etal/></person-group><article-title>New RNA motifs suggest an expanded scope for riboswitches in bacterial genetic control</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2004</year><volume>101</volume><fpage>6421</fpage><pub-id pub-id-type="pmid">15096624</pub-id></citation></ref><ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mandal</surname><given-names>M</given-names></name><name><surname>Breaker</surname><given-names>RR</given-names></name></person-group><article-title>Gene regulation by riboswitches</article-title><source>Nature Rev. Mol. Cell Biol</source><year>2004</year><volume>5</volume><fpage>451</fpage><pub-id pub-id-type="pmid">15173824</pub-id></citation></ref><ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sudarsan</surname><given-names>N</given-names></name><name><surname>Barrick</surname><given-names>JE</given-names></name><name><surname>Breaker</surname><given-names>RR</given-names></name></person-group><article-title>Metabolite-binding RNA domains are present in the genes of eukaryotes</article-title><source>RNA</source><year>2003</year><volume>9</volume><fpage>644</fpage><pub-id pub-id-type="pmid">12756322</pub-id></citation></ref><ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roth</surname><given-names>A</given-names></name><name><surname>Winkler</surname><given-names>W</given-names></name><name><surname>Regulski</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Lim</surname><given-names>J</given-names></name><name><surname>Jona</surname><given-names>I</given-names></name><name><surname>Barrick</surname><given-names>J</given-names></name><name><surname>Ritwik</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><etal/></person-group><article-title>A riboswitch selective for the queuosine precursor preQ(1) contains an unusually small aptamer domain</article-title><source>Nat. Struct. Mol. Biol</source><year>2007</year><volume>14</volume><fpage>308</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">17384645</pub-id></citation></ref><ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>XG</given-names></name><name><surname>Ofengand</surname><given-names>J</given-names></name><name><surname>Santi</surname><given-names>DV</given-names></name></person-group><article-title><italic>In Vitro</italic> Methylation of <italic>Escherichia coli</italic> 16S&#x02009;rRNA by tRNA (m<sup>5</sup>U54)-Methyltransferase</article-title><source>Biochemistry</source><year>1994</year><volume>33</volume><fpage>2255</fpage><lpage>2261</lpage><pub-id pub-id-type="pmid">8117682</pub-id></citation></ref><ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noon</surname><given-names>KR</given-names></name><name><surname>Bruenger</surname><given-names>E</given-names></name><name><surname>McCloskey</surname><given-names>JA</given-names></name></person-group><article-title>Posttranscriptional modifications in 16S and 23S&#x02009;rRNAs of the archaeal hyperthermophile Sulfolobus solfataricus</article-title><source>J. Bacteriol</source><year>1998</year><volume>180</volume><fpage>2883</fpage><lpage>2888</lpage><pub-id pub-id-type="pmid">9603876</pub-id></citation></ref><ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pain</surname><given-names>VM</given-names></name></person-group><article-title>Initiation of protein synthesis in eukaryotic cells</article-title><source>Eur. J. Biochem</source><year>1996</year><volume>236</volume><fpage>747</fpage><pub-id pub-id-type="pmid">8665893</pub-id></citation></ref><ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Macejak</surname><given-names>DG</given-names></name><name><surname>Sarnow</surname><given-names>P</given-names></name></person-group><article-title>Internal Initiation Of Translation Mediated By The 5&#x02032; Leader Of A Cellular Messenger-Rna</article-title><source>Nature</source><year>1991</year><volume>353</volume><fpage>90</fpage><pub-id pub-id-type="pmid">1652694</pub-id></citation></ref><ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gingras</surname><given-names>AC</given-names></name><name><surname>Raught</surname><given-names>B</given-names></name><name><surname>Sonenberg</surname><given-names>N</given-names></name></person-group><article-title>eIF4 initiation factors: Effectors of mRNA recruitment to ribosomes and regulators of translation</article-title><source>Annu. Rev. Biochem</source><year>1999</year><volume>68</volume><fpage>913</fpage><pub-id pub-id-type="pmid">10872469</pub-id></citation></ref><ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Curnow</surname><given-names>AW</given-names></name><name><surname>Kung</surname><given-names>FL</given-names></name><name><surname>Koch</surname><given-names>KA</given-names></name><name><surname>Garcia</surname><given-names>GA</given-names></name></person-group><article-title>tRNA-guanine transglycosylase from <italic>Escherichia coli</italic>: gross tRNA structural requirements for recognition</article-title><source>Biochemistry</source><year>1993</year><volume>32</volume><fpage>5239</fpage><lpage>5246</lpage><pub-id pub-id-type="pmid">8494901</pub-id></citation></ref><ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Curnow</surname><given-names>AW</given-names></name><name><surname>Garcia</surname><given-names>GA</given-names></name></person-group><article-title>tRNA-guanine transglycosylase from <italic>Escherichia coli</italic> - minimal tRNA structure and sequence requirements for recognition</article-title><source>J. Biol. Chem</source><year>1995</year><volume>270</volume><fpage>17264</fpage><lpage>17267</lpage><pub-id pub-id-type="pmid">7615526</pub-id></citation></ref><ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Curnow</surname><given-names>AW</given-names></name><name><surname>Garcia</surname><given-names>GA</given-names></name></person-group><article-title>tRNA-guanine transglycosylase from <italic>Escherichia coli</italic>: recognition of dimeric, unmodified tRNA<sup>Tyr</sup></article-title><source>Biochimie</source><year>1994</year><volume>76</volume><fpage>1183</fpage><lpage>1191</lpage><pub-id pub-id-type="pmid">7748954</pub-id></citation></ref><ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kittendorf</surname><given-names>JD</given-names></name><name><surname>Barcomb</surname><given-names>LM</given-names></name><name><surname>Nonekowski</surname><given-names>ST</given-names></name><name><surname>Garcia</surname><given-names>GA</given-names></name></person-group><article-title>tRNA-guanine transglycosylase from <italic>Escherichia coli</italic>: Molecular mechanism and role of aspartate 89</article-title><source>Biochemistry</source><year>2001</year><volume>40</volume><fpage>14123</fpage><lpage>14133</lpage><pub-id pub-id-type="pmid">11714265</pub-id></citation></ref><ref id="B33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Migawa</surname><given-names>MT</given-names></name><name><surname>Hinkley</surname><given-names>JM</given-names></name><name><surname>Hoops</surname><given-names>GC</given-names></name><name><surname>Townsend</surname><given-names>LB</given-names></name></person-group><article-title>A two step synthesis of the nucleoside Q precursor 2-amino-5-cyanopyrrolo[2,3-<italic>d</italic>]pyrimidin-4-one (PreQ<sub>0</sub>)</article-title><source>Synth. Commun</source><year>1996</year><volume>26</volume><fpage>3317</fpage><lpage>3322</lpage></citation></ref><ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>CS</given-names></name><name><surname>Hoops</surname><given-names>GC</given-names></name><name><surname>Earl</surname><given-names>RA</given-names></name><name><surname>Townsend</surname><given-names>LB</given-names></name></person-group><article-title>Synthesis of pyrrolo[2,3-d]pyrimidines that are structurally related to methylated guanosines from tRNA and the nucleoside Q analogs, PreQ(0) and PreQ(1)</article-title><source>Nucleos Nucleot</source><year>1997</year><volume>16</volume><fpage>347</fpage><lpage>364</lpage></citation></ref><ref id="B35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Durand</surname><given-names>JM</given-names></name><name><surname>Okada</surname><given-names>N</given-names></name><name><surname>Tobe</surname><given-names>T</given-names></name><name><surname>Watarai</surname><given-names>M</given-names></name><name><surname>Fukuda</surname><given-names>I</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Nakata</surname><given-names>N</given-names></name><name><surname>Komatsu</surname><given-names>K</given-names></name><name><surname>Yoshikawa</surname><given-names>M</given-names></name><etal/></person-group><article-title><italic>vacC</italic>, a virulence-associated chromosomal locus of <italic>Shigella flexneri</italic>, is homologous to <italic>tgt</italic>, a gene encoding tRNA-guanine transglycosylase (TGT) of <italic>Escherichia coli</italic> K-12</article-title><source>J. Bacteriol</source><year>1994</year><volume>176</volume><fpage>4627</fpage><lpage>4634</lpage><pub-id pub-id-type="pmid">8045893</pub-id></citation></ref><ref id="B36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bj&#x000f6;rk</surname><given-names>GR</given-names></name></person-group><article-title>Genetic dissection of synthesis and function of modified nucleosides in bacterial transfer RNA</article-title><source>Prog. Nucleic Acids Res. Mol. Biol</source><year>1995</year><volume>50</volume><fpage>263</fpage><lpage>338</lpage></citation></ref><ref id="B37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>QA</given-names></name><name><surname>Curran</surname><given-names>JF</given-names></name><name><surname>Bjork</surname><given-names>GR</given-names></name></person-group><article-title>The methyl group of the N-6-methyl-N-6-threonylcarbamoyladenosine in tRNA of Escherichia coli modestly improves the efficiency of the tRNA</article-title><source>J. Bacteriol</source><year>1998</year><volume>180</volume><fpage>1808</fpage><lpage>1813</lpage><pub-id pub-id-type="pmid">9537379</pub-id></citation></ref><ref id="B38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noguchi</surname><given-names>S</given-names></name><name><surname>Nishimura</surname><given-names>Y</given-names></name><name><surname>Hirota</surname><given-names>Y</given-names></name><name><surname>Nishimura</surname><given-names>S</given-names></name></person-group><article-title>Isolation and characterization of an <italic>Escherichia coli</italic> mutant lacking tRNA-guanine transglycosylase</article-title><source>J. Biol. Chem</source><year>1982</year><volume>257</volume><fpage>6544</fpage><lpage>6550</lpage><pub-id pub-id-type="pmid">6804468</pub-id></citation></ref><ref id="B39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rordorff</surname><given-names>BF</given-names></name><name><surname>Kearns</surname><given-names>DR</given-names></name></person-group><article-title>Nuclear Magnetic Resonance Investigation of the Base-Pairing Structure of <italic>Escherichia coli</italic> tRNA<sup>Tyr</sup> Monomer and Dimer Conformations</article-title><source>Biochemistry</source><year>1976</year><volume>15</volume><fpage>3320</fpage><lpage>3330</lpage><pub-id pub-id-type="pmid">782517</pub-id></citation></ref><ref id="B40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Massenet</surname><given-names>S</given-names></name><name><surname>Motorin</surname><given-names>Y</given-names></name><name><surname>Lafontaine</surname><given-names>DLJ</given-names></name><name><surname>Hurt</surname><given-names>EC</given-names></name><name><surname>Grosjean</surname><given-names>H</given-names></name><name><surname>Branlant</surname><given-names>C</given-names></name></person-group><article-title>Pseudouridine mapping in the Saccharomyces cerevisiae spliceosomal U small nuclear RNAs (snRNAs) reveals that pseudouridine synthase Pus1p exhibits a dual substrate specificity for U2 snRNA and tRNA</article-title><source>Mol. Cell. Biol</source><year>1999</year><volume>19</volume><fpage>2142</fpage><lpage>2154</lpage><pub-id pub-id-type="pmid">10022901</pub-id></citation></ref><ref id="B41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maden</surname><given-names>BEH</given-names></name></person-group><article-title>The numerous modified nucleotides in eukaryotic ribosomal RNA</article-title><source>Prog. Nucleic Acids Res. Mol. Biol</source><year>1990</year><volume>39</volume><fpage>241</fpage><lpage>300</lpage></citation></ref><ref id="B42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>XR</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Ivanetich</surname><given-names>KM</given-names></name><name><surname>Santi</surname><given-names>DV</given-names></name></person-group><article-title>Molecular recognition of tRNA by tRNA pseudouridine 55 synthase</article-title><source>Biochemistry</source><year>1998</year><volume>37</volume><fpage>339</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">9425055</pub-id></citation></ref><ref id="B43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horne</surname><given-names>DA</given-names></name><name><surname>Rood</surname><given-names>K</given-names></name><name><surname>Levine</surname><given-names>E</given-names></name><name><surname>Ofengand</surname><given-names>J</given-names></name></person-group><article-title>RNA substrate recognition by E-coli pseudouridine synthase (rluA) with dual substrate specificity</article-title><source>Abstr. Pap. Am. Chem. Soc</source><year>1997</year><volume>213</volume><fpage>308</fpage></citation></ref><ref id="B44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raychaudhuri</surname><given-names>S</given-names></name><name><surname>Niu</surname><given-names>LH</given-names></name><name><surname>Conrad</surname><given-names>J</given-names></name><name><surname>Lane</surname><given-names>BG</given-names></name><name><surname>Ofengand</surname><given-names>J</given-names></name></person-group><article-title>Functional effect of deletion and mutation of the Escherichia coli ribosomal RNA and tRNA pseudouridine synthase RluA</article-title><source>J. Biol. Chem</source><year>1999</year><volume>274</volume><fpage>18880</fpage><pub-id pub-id-type="pmid">10383384</pub-id></citation></ref><ref id="B45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nonekowski</surname><given-names>ST</given-names></name><name><surname>Garcia</surname><given-names>GA</given-names></name></person-group><article-title>tRNA Recognition by the <italic>E. coli</italic> TGT: the Role of U33 in U-G-U Sequence Recognition</article-title><source>RNA</source><year>2001</year><volume>7</volume><fpage>1432</fpage><lpage>1441</lpage><pub-id pub-id-type="pmid">11680848</pub-id></citation></ref><ref id="B46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goodenough-Lashua</surname><given-names>DM</given-names></name><name><surname>Garcia</surname><given-names>GA</given-names></name></person-group><article-title>tRNA-Guanine Transglycosylase from <italic>Escherichia coli</italic>: a Ping-Pong Kinetic Mechanism is Consistent with Nucleophilic Catalysis</article-title><source>Bioorg. Chem</source><year>2003</year><volume>31</volume><fpage>331</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">12877882</pub-id></citation></ref><ref id="B47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kittendorf</surname><given-names>JD</given-names></name><name><surname>Sgraja</surname><given-names>T</given-names></name><name><surname>Reuter</surname><given-names>K</given-names></name><name><surname>Klebe</surname><given-names>G</given-names></name><name><surname>Garcia</surname><given-names>GA</given-names></name></person-group><article-title>An essential role for aspartate 264 in catalysis by tRNA-guanine transglycosylase from <italic>Escherichia coli</italic></article-title><source>J. Biol. Chem</source><year>2003</year><volume>278</volume><fpage>42369</fpage><lpage>42376</lpage><pub-id pub-id-type="pmid">12909636</pub-id></citation></ref><ref id="B48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>XJ</given-names></name><name><surname>Huang</surname><given-names>RH</given-names></name></person-group><article-title>Chemical trapping and crystal structure of a catalytic tRNA guanine transglycosylase covalent intermediate</article-title><source>Nat. Struct. Biol</source><year>2003</year><volume>10</volume><fpage>781</fpage><lpage>788</lpage><pub-id pub-id-type="pmid">12949492</pub-id></citation></ref><ref id="B49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stengl</surname><given-names>B</given-names></name><name><surname>Meyer</surname><given-names>EA</given-names></name><name><surname>Heine</surname><given-names>A</given-names></name><name><surname>Brenk</surname><given-names>R</given-names></name><name><surname>Diederich</surname><given-names>F</given-names></name><name><surname>Klebe</surname><given-names>G</given-names></name></person-group><article-title>Crystal Structures of tRNA-guanine Transglycosylase (TGT) in Complex with Novel and Potent Inhibitors Unravel Pronounced Induced-fit Adaptations and Suggest Dimer Formation Upon Substrate Binding</article-title><source>J. Mol. Biol</source><year>2007</year><comment>DOI:10.1016/j.jmb.2007.04.008</comment></citation></ref></ref-list></back></article> 